TPIA Stock Overview
Focuses on psychedelics for the treatment of mental health issues.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Mycotopia Therapies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.026 |
| 52 Week High | US$0.18 |
| 52 Week Low | US$0.013 |
| Beta | 2.51 |
| 11 Month Change | 22.59% |
| 3 Month Change | -13.37% |
| 1 Year Change | 9.48% |
| 33 Year Change | -98.38% |
| 5 Year Change | n/a |
| Change since IPO | -99.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| TPIA | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -0.04% | 0.3% | 0.9% |
| 1Y | 9.5% | 12.0% | 32.3% |
Return vs Industry: TPIA underperformed the US Healthcare industry which returned 12% over the past year.
Return vs Market: TPIA underperformed the US Market which returned 32.3% over the past year.
Price Volatility
| TPIA volatility | |
|---|---|
| TPIA Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: TPIA's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine TPIA's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1 | Ben Kaplan | www.mycotopiatherapies.com |
Mycotopia Therapies, Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, palliative care, depression, and anxiety. The company is based in Miami, Florida.
Mycotopia Therapies, Inc. Fundamentals Summary
| TPIA fundamental statistics | |
|---|---|
| Market cap | US$387.17k |
| Earnings (TTM) | -US$1.50m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.3x
P/E RatioIs TPIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TPIA income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$1.50m |
| Earnings | -US$1.50m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.10 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -43.2% |
How did TPIA perform over the long term?
See historical performance and comparison